Torthaí cuardaigh - Pierre‐Emmanuel Morange
- 1 - 20 toradh as 74 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Current knowledge on the genetics of incident venous thrombosis de réir Pierre‐Emmanuel Morange, David‐Alexandre Trégouët
Foilsithe / Cruthaithe 2013Artigo -
2
-
3
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk de réir I. Juhan-Vague, Marie‐Christine Alessi, Alenka Mavri, Pierre‐Emmanuel Morange
Foilsithe / Cruthaithe 2003Revisão -
4
Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral‐ or bacterial‐oriented immune responses de réir P Bourgoin, Géraldine Biéchelé, Inès Ait Belkacem, Pierre‐Emmanuel Morange, Fabrice Malergue
Foilsithe / Cruthaithe 2020Artigo -
5
-
6
-
7
PAI-1 Produced Ex Vivo by Human Adipose Tissue Is Relevant to PAI-1 Blood Level de réir Pierre‐Emmanuel Morange, Marie‐Christine Alessi, Monique Verdier, Daniel Casanova, G. Magalon, I. Juhan‐Vague
Foilsithe / Cruthaithe 1999Artigo -
8
-
9
High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronar... de réir T. Cuisset, Corinne Frère, Jacques Quilici, Franck Barbou, Pierre‐Emmanuel Morange, Thomas Hovasse, J‐L. BONNET, Marie‐Christine Alessi
Foilsithe / Cruthaithe 2005Artigo -
10
Thrombin-Activatable Fibrinolysis Inhibitor Antigen Levels and Cardiovascular Risk Factors de réir I. Juhan-Vague, Jean‐François Renucci, M. Grimaux, Pierre‐Emmanuel Morange, J. Gouvernet, Y Gourmelin, Marie‐Christine Alessi
Foilsithe / Cruthaithe 2000Artigo -
11
Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat de réir Delphine Bastelica, Pierre‐Emmanuel Morange, B Berthet, Hélène Borghi, Odile Lacroix, Michel Grino, I. Juhan‐Vague, Marie‐Christine Alessi
Foilsithe / Cruthaithe 2002Artigo -
12
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. de réir Marie‐Christine Alessi, Delphine Bastelica, Pierre‐Emmanuel Morange, B Berthet, Isabelle Leduc, Monique Verdier, O Geel, I. Juhan-Vague
Foilsithe / Cruthaithe 2000Artigo -
13
The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies de réir Jessica Dennis, Candice Y. Johnson, Adeniyi Samuel Adediran, Mariza de Andrade, John A. Heit, Pierre‐Emmanuel Morange, David‐Alexandre Trégouët, France Gagnon
Foilsithe / Cruthaithe 2012Revisão -
14
Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary S... de réir Thomas Cuisset, Corinne Frère, Jacques Quilici, Pierre‐Emmanuel Morange, Lyassine Nait-Saïdi, Joseph Carvajal, Agnès Lehmann, M. Lambert, J Bonnet, Marie‐Christine Alessi
Foilsithe / Cruthaithe 2006Artigo -
15
Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort de réir Pierre‐Emmanuel Morange, David‐Alexandre Trégouët, Corinne Frère, Noémie Saut, Laurence Pellegrina, Marie‐Christine Alessi, Sophie Visvikis‐Siest, Laurence Tiret, I. Juhan‐Vague
Foilsithe / Cruthaithe 2004Artigo -
16
Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels de réir Guillemette Antoni, Tiphaine Oudot‐Mellakh, Apostolos Dimitromanolakis, Marine Germain, William Cohen, Philip Wells, Mark Lathrop, France Gagnon, Pierre‐Emmanuel Morange, David‐Alexandre Trégouët
Foilsithe / Cruthaithe 2011Revisão -
17
Plasma Biomarkers and Identification of Resilient Metabolic Disruptions in Patients With Venous Thromboembolism Using a Metabolic Systems Approach de réir Karl Fraser, Nicole C. Roy, Louisa Goumidi, Alexandre Verdu, Pierre Suchon, Felipe L. Valentim, David‐Alexandre Trégouët, Pierre‐Emmanuel Morange, Jean‐Charles Martin
Foilsithe / Cruthaithe 2020Artigo -
18
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study de réir Pierre‐Emmanuel Morange, Laurence Tiret, Noémie Saut, G. Luc, Dominique Arveiler, Jean Ferrières, Philippe Amouyel, A. Evans, Pierre Ducimetière, François Cambien, I. Juhan‐Vague
Foilsithe / Cruthaithe 2004Artigo -
19
Multilocus Genetic Risk Scores for Venous Thromboembolism Risk Assessment de réir José Manuel Soria, Pierre‐Emmanuel Morange, Joan Vila, Juan Carlos Souto, Manel Moyano, David‐Alexandre Trégouët, José Mateo, Noémi Saut, Eduardo Salas, Roberto Elosúa
Foilsithe / Cruthaithe 2014Artigo -
20
Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders de réir Thomas Cuisset, Corinne Frère, Jacques Quilici, Pierre‐Emmanuel Morange, Jean-Philippe Mouret, Laurent Bali, Pierre-Julien Moro, M. Lambert, Marie‐Christine Alessi, Jean Louis Bonnet
Foilsithe / Cruthaithe 2008Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Biology
Gene
Genetics
Genotype
Single-nucleotide polymorphism
Genome-wide association study
Cardiology
Platelet
Immunology
Thrombosis
Genetic association
Bioinformatics
Allele
Disease
Endocrinology
Venous thromboembolism
Genetic variants
Myocardial infarction
Odds ratio
Virology
Aspirin
Chemistry
Clopidogrel
Coronavirus disease 2019 (COVID-19)
Immune system
Infectious disease (medical specialty)
Mendelian randomization
Plasminogen activator